Perpetual Ltd lessened its position in shares of Fabrinet (NYSE:FN – Free Report) by 17.5% in the 4th quarter, HoldingsChannel reports. The fund owned 5,223 shares of the technology company’s stock after selling 1,105 shares during the period. Perpetual Ltd’s holdings in Fabrinet were worth $1,148,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of FN. Wedge Capital Management L L P NC acquired a new stake in Fabrinet in the fourth quarter worth about $63,222,000. Hennion & Walsh Asset Management Inc. boosted its stake in Fabrinet by 18.4% in the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 6,658 shares of the technology company’s stock worth $1,464,000 after purchasing an additional 1,037 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. grew its position in Fabrinet by 67.5% during the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 4,369 shares of the technology company’s stock worth $961,000 after purchasing an additional 1,760 shares during the last quarter. Park Avenue Securities LLC grew its position in Fabrinet by 21.4% during the 4th quarter. Park Avenue Securities LLC now owns 8,113 shares of the technology company’s stock worth $1,784,000 after purchasing an additional 1,432 shares during the last quarter. Finally, Salem Investment Counselors Inc. purchased a new position in shares of Fabrinet in the fourth quarter worth $518,000. Hedge funds and other institutional investors own 97.38% of the company’s stock.
Fabrinet Stock Up 6.2 %
Fabrinet stock opened at $267.74 on Thursday. Fabrinet has a 52 week low of $159.69 and a 52 week high of $281.79. The firm has a market cap of $9.71 billion, a price-to-earnings ratio of 31.69 and a beta of 0.93. The business’s 50-day moving average price is $232.41 and its 200 day moving average price is $235.55.
Wall Street Analyst Weigh In
Several research firms recently issued reports on FN. B. Riley downgraded Fabrinet from a “neutral” rating to a “sell” rating and cut their target price for the company from $194.00 to $178.00 in a research report on Wednesday, November 20th. Barclays initiated coverage on Fabrinet in a report on Thursday, November 14th. They issued an “equal weight” rating and a $292.00 price objective on the stock. Finally, Needham & Company LLC began coverage on Fabrinet in a research report on Tuesday, November 5th. They issued a “buy” rating and a $280.00 target price on the stock. One analyst has rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $252.14.
Read Our Latest Research Report on Fabrinet
Fabrinet Profile
Fabrinet provides optical packaging and precision optical, electro-mechanical, and electronic manufacturing services in North America, the Asia-Pacific, and Europe. The company offers a range of advanced optical and electro-mechanical capabilities in the manufacturing process, including process design and engineering, supply chain management, manufacturing, printed circuit board assembly, advanced packaging, integration, final assembly, and testing.
Featured Articles
- Five stocks we like better than Fabrinet
- Breakout Stocks: What They Are and How to Identify Them
- Oracle Announces Game-Changing News for the AI Industry
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Best Aerospace Stocks Investing
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding FN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fabrinet (NYSE:FN – Free Report).
Receive News & Ratings for Fabrinet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fabrinet and related companies with MarketBeat.com's FREE daily email newsletter.